| Circular RNAs in cancer: new insights into functions and implications in ovarian cancer |
36 |
| Biomarkers and algorithms for diagnosis of ovarian cancer: CA HE RMI and ROMA, a review |
30 |
| Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis |
21 |
| Wnt/beta-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis |
20 |
| Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study |
20 |
| The role of the endocannabinoid system in female reproductive tissues |
16 |
| Circular RNAs: biogenesis, expression and their potential roles in reproduction |
14 |
| The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention |
14 |
| Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status |
14 |
| Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors |
13 |
| Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer |
12 |
| Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome |
12 |
| The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome |
12 |
| Exosomal miR-1290 is a potential of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types |
11 |
| The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis |
11 |
| Quercetin: a natural compound for ovarian cancer treatment |
11 |
| Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model |
11 |
| Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand-1 (PD-L1) in ovarian cancer |
11 |
| Fresh versus frozen embryo transfer for full-term singleton birth: a retrospective cohort study |
10 |
| Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death |
10 |
| Pregnancy after drug-free in vitro activation of follicles and fresh tissue autotransplantation in primary ovarian insufficiency patient: a case report and literature review |
9 |
| Effects of myo-inositol plus alphalactalbumin in myo-inositol-resistant PCOS women |
9 |
| Adipokine RBP4 drives ovarian cancer cell migration |
9 |
| Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis |
9 |
| P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling |
9 |
| MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3 beta/Snail signaling pathway by targeting ATM |
8 |
| DHEA-induced ovarian hyperfibrosis is mediated by TGF-beta signaling pathway |
8 |
| Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study |
8 |
| miR-552 promotes ovarian cancer progression by regulating PTEN pathway |
8 |
| Hypoxia-inducible factor-1 induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells |
8 |
| Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers |
8 |
| PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma |
7 |
| Melatonin attenuates palmitic acid-induced mouse granulosa cells apoptosis via endoplasmic reticulum stress |
7 |
| Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study |
7 |
| Pregnancy and oncologic outcomes of early stage low grade epithelial ovarian cancer after fertility sparing surgery: a retrospective study in one tertiary hospital of China |
7 |
| Decellularization of the mouse ovary: comparison of different scaffold generation protocols for future ovarian bioengineering |
7 |
| Determination of sialic acid in saliva by means of surface-enhanced Raman spectroscopy as a marker in adnexal mass patients: ovarian cancer vs benign cases |
7 |
| Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors |
7 |
| MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ |
7 |
| MicroRNA-424/503 cluster members regulate bovine granulosa cell proliferation and cell cycle progression by targeting SMAD7 gene through activin signalling pathway |
7 |
| Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion |
7 |
| New national outcome data on fresh versus cryopreserved donor oocytes |
7 |
| Aberrant DNA methylation suppresses expression of estrogen receptor 1 (ESR1) in ovarian endometrioma |
7 |
| Discordant anti-mullerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth? |
6 |
| TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers |
6 |
| Characterization of ovarian cancer cells an tissues by Fourier transform infrared spectroscopy |
6 |
| Quercetin increases the antioxidant capacity of the ovary in menopausal rats and in ovarian granulosa cell culture in vitro |
6 |
| Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets |
6 |
| A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two-centers experience |
6 |
| Age-dependent difference in impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors |
6 |
